Reply to Struys: Role of biomarker of 2-hydroxyglutarate in acute myeloid leukemia

Comment

Yang Shen et al. Proc Natl Acad Sci U S A. 2013.

. 2013 Dec 17;110(51):E4940.

doi: 10.1073/pnas.1319936110.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.
Wang JH, Chen WL, Li JM, Wu SF, Chen TL, Zhu YM, Zhang WN, Li Y, Qiu YP, Zhao AH, Mi JQ, Jin J, Wang YG, Ma QL, Huang H, Wu DP, Wang QR, Li Y, Yan XJ, Yan JS, Li JY, Wang S, Huang XJ, Wang BS, Jia W, Shen Y, Chen Z, Chen SJ. Wang JH, et al. Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17017-22. doi: 10.1073/pnas.1315558110. Epub 2013 Sep 30. Proc Natl Acad Sci U S A. 2013. PMID: 24082129 Free PMC article. Clinical Trial.
2-Hydroxyglutarate is not a metabolite; D-2-hydroxyglutarate and L-2-hydroxyglutarate are!
Struys EA. Struys EA. Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4939. doi: 10.1073/pnas.1318777110. Epub 2013 Dec 6. Proc Natl Acad Sci U S A. 2013. PMID: 24319093 Free PMC article. No abstract available.

1. Struys EA. 2-Hydroxyglutarate is not a metabolite; d-2-hydroxyglutarate and l-2-hydroxyglutarate are! Proc Natl Acad Sci USA. 2013;110:E4939. - PMC - PubMed
1. Wang J-H, et al. Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. Proc Natl Acad Sci USA. 2013;110(42):17017–17022. - PMC - PubMed
1. Van Schaftingen E, Rzem R, Veiga-da-Cunha M. L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis. 2009;32(2):135–142. - PubMed
1. Rakheja D, Medeiros LJ, Bevan S, Chen W. The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms. Front Oncol. 2013;3:169. - PMC - PubMed
1. Sellner L, et al. Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations. Eur J Haematol. 2010;85(5):457–459. - PubMed